Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata

NCT01512953 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

522

Enrollment

OTHER

Sponsor class

Conditions

Coronary Stenting

Interventions

DRUG: Lansoprazole

Sponsor

Università degli Studi di Ferrara